Literature DB >> 15463183

Iron and malaria.

S J Oppenheimer1.   

Abstract

Iron deficiency is common in the developing world; consequently, programmes of presumptive therapy and mass supplementation have been introduced in several countries. In this article Stephen Oppenheimer suggests caution, as recent evidence suggests that these practices may actually increase the likelihood of the subject developing patent malaria in endemic areas. This may be especially significant in infants, who are less likely to be immune to malaria, and in pregnant women, who are often routinely given iron supplements and in whom malaria may damage the foetus.

Entities:  

Year:  1989        PMID: 15463183     DOI: 10.1016/0169-4758(89)90006-9

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  5 in total

1.  Sub-lethal effects of pathogens can lead to the evolution of lower virulence in multiple infections.

Authors:  Solveig Schjørring; Jacob C Koella
Journal:  Proc Biol Sci       Date:  2003-01-22       Impact factor: 5.349

Review 2.  Micronutrients and immune function: some recent developments.

Authors:  D I Thurnham
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine.

Authors:  O Domarle; G Blampain; H Agnaniet; T Nzadiyabi; J Lebibi; J Brocard; L Maciejewski; C Biot; A J Georges; P Millet
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Antiplasmodial activity of artecyclopentyl mether a new artemisinin derivative and its effect on pathogenesis in Plasmodium yoelii nigeriensis infected mice.

Authors:  Jyoti Agarwal; Suriya Pratap Singh; Debabrata Chanda; Dnyaneshwar Umrao Bawankule; Rajendra Singh Bhakuni; Anirban Pal
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

Review 5.  Pathogenesis of anemia in malaria: a concise review.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2007-09-16       Impact factor: 2.289

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.